Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Revenue

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹9,620 Cr₹8,508 Cr₹8,005 Cr₹7,939 Cr₹7,673 Cr

What is the latest Revenue of TORRENT PHARMACEUTICALS ?

The latest Revenue ratio of TORRENT PHARMACEUTICALS is ₹9,620 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹9,620 Cr
Mar2023₹8,508 Cr
Mar2022₹8,005 Cr
Mar2021₹7,939 Cr
Mar2020₹7,673 Cr

How is Revenue of TORRENT PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹9,620 Cr
13.07
Mar2023 ₹8,508 Cr
6.29
Mar2022 ₹8,005 Cr
0.82
Mar2021 ₹7,939 Cr
3.47
Mar2020 ₹7,673 Cr -

Compare Revenue of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹110,330.2 Cr 3.4% 0.5% 12.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,768.0 Cr 0.4% -1.2% 12.2% Stock Analytics
DIVIS LABORATORIES ₹178,468.0 Cr 2.6% 8.4% 48.5% Stock Analytics
CIPLA ₹121,326.0 Cr -0.1% 0.5% 1.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,757.0 Cr 3.2% 11.8% 11.4% Stock Analytics
MANKIND PHARMA ₹98,512.2 Cr 1.4% -6.4% 11.8% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

3.4%

0.5%

12.8%

SENSEX

0.3%

0.7%

8.8%


You may also like the below Video Courses